Skip Nav Destination
Issues
Research Articles
Association of Regimens of Hormone Replacement Therapy to Prognostic Factors among Women Diagnosed with Breast Cancer Aged 50–64 Years
Janet R. Daling; Kathleen E. Malone; David R. Doody; Lynda F. Voigt; Leslie Bernstein; Polly A. Marchbanks; Ralph J. Coates; Sandra A. Norman; Linda K. Weiss; Giske Ursin; Ronald T. Burkman; Dennis Deapen; Suzanne G. Folger; Jill A. McDonald; Michael S. Simon; Brian L. Strom; Robert Spirtas
Phase I Pharmacokinetic and Pharmacodynamic Analysis of Unconjugated Soy Isoflavones Administered to Individuals with Cancer
Chris H. Takimoto; Kira Glover; Xiaoke Huang; Steven A. Hayes; Lilia Gallot; Mary Quinn; Borko D. Jovanovic; Alla Shapiro; Leticia Hernandez; Andrew Goetz; Victor Llorens; Ronald Lieberman; James A. Crowell; Brett A. Poisson; Raymond C. Bergan
Alcohol Flushing, Alcohol and Aldehyde Dehydrogenase Genotypes, and Risk for Esophageal Squamous Cell Carcinoma in Japanese Men
Tetsuji Yokoyama; Akira Yokoyama; Hoichi Kato; Toshimasa Tsujinaka; Manabu Muto; Tai Omori; Tatsumasa Haneda; Yoshiya Kumagai; Hiroyasu Igaki; Masako Yokoyama; Hiroshi Watanabe; Haruko Yoshimizu
Polymorphisms of the DNA Repair Genes XRCC1, XRCC3, XPD, Interaction with Environmental Exposures, and Bladder Cancer Risk in a Case-Control Study in Northern Italy
Min Shen; Rayjean J. Hung; Paul Brennan; Christian Malaveille; Francesco Donato; Donatella Placidi; Angela Carta; Agnes Hautefeuille; Paolo Boffetta; Stefano Porru
Short Communications
Null Results in Brief
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.